Status:
WITHDRAWN
Effect of NMBA on Surgical Conditions in THR
Lead Sponsor:
Algemeen Ziekenhuis Maria Middelares
Conditions:
Surgery
Postoperative Pain
Eligibility:
All Genders
18-90 years
Phase:
PHASE4
Brief Summary
During Total hip replacement arthroplasty (THA), the hip joint first must be luxated in order to have access to the joints. A lot of force and torque must be carried out on the joint to perform this m...
Detailed Description
2X20 patients are randomised: Rocuronium-group (R-group) and Placebo-group (P-group). All patients receive standardised multimodal intravenous analgesia. After standardised induction of anasthesia an...
Eligibility Criteria
Inclusion
- signed informed consent
- eligible for primary THA
- BMI \<35
Exclusion
- neurological or psychiatric disorders
- intolerance or allergy against investigational drugs or any of the drugs used in the standardized analgetics scheme (acetaminophen, diclofenac, ketamine, clonidine, lidocaine)
Key Trial Info
Start Date :
December 15 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2018
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03369782
Start Date
December 15 2017
End Date
May 31 2018
Last Update
March 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AZ Maria Middelares
Ghent, Oost-Vlaanderen, Belgium, 9000